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Abstract: The addition of silver nanoparticles (AgNPs) to biomedical textiles can be of great interest 
to protect the materials against microorganisms and prevent their spread. However, the human and 
environmental over‐exposure to AgNPs is leading to numerous concerns due to their toxicity. In 
this work, AgNPs were stabilized onto polyamide 6.6 fabrics (PA66) through atmospheric dielectric 
barrier discharge (DBD) plasma treatment and the use of chitosan (Ch) layers applied by spray. DBD 
plasma treatment revealed a crucial role in AgNPs adhesion (4.8 and 6.3 At%). A first layer of Ch 
decreased the AgNPs adhesion in both untreated and DBD plasma‐treated samples but treated 
samples show higher concentration (1.7 and 4.1 At%). The antibacterial activity was evaluated 
against Staphylococcus aureus and Escherichia coli after 2 and 24 h, showing a superior action in all 
samples with DBD plasma treatment after 24 h. The Ch in the first layers of the composites delayed 
the antimicrobial action of the samples but it also may enhance antimicrobial action. The obtained 
coatings will allow the development of novel and safe wound dressings with improved AgNPs 
deposition, controlled ions released and consequently, manage the antimicrobial performance and 
minimize the AgNPs side effects. 
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1. Introduction 
The functionalization of biomedical textiles with silver nanoparticles (AgNPs) has received a 
special interest due to their unique properties namely their increased surface‐to‐volume ratio, that 
makes them potent antimicrobial agents at reduced concentrations [1]. AgNPs protect textiles against 
microorganisms and prevent their spread, which is extremely useful in biomedical textiles applied in 
case of bacterial infections, including multidrug‐resistant bacteria, and healthcare‐associated 
infections [2]. Particularly in wound dressings, textiles can act as a container or silver ions release 
system to prevent bacterial infections and facilitate the wound healing process [3]. The AgNPs 
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content in the dressings may be introduced as a coating on one or both external surfaces and/or 
incorporated in the fibres. In all strategies, a moist wound environment is needed to activate the 
release of silver ions and, therefore, induce an antimicrobial effect [4]. AgNPs are one of the most 
marketable nanomaterials worldwide due to their innovative and promising properties. However, 
with their extensive commercial use and increased production, several concerns about the human 
and environmental over‐exposure during manufacturing, handling and disposal have emerged [5]. 
Some experiments were performed to understand the AgNPs toxicity to biological systems and the 
results showed DNA perturbations and metabolism damages in healthy cells after the exposure. 
AgNPs can enter in the cells by passing through biological membranes, affecting their physiology 
due to their small size [6]. AgNPs may cause a huge impact also in the environment due to their high 
surface area and reactivity. They can experience numerous transformations, difficult to predict, 
including oxidation or reduction, agglomeration or sedimentation, that modifies their behavior [7]. 
Thus, it becomes imperative to find out methods to improve the AgNPs antimicrobial effect without 
increasing the applied concentration and avoid their uncontrollable release to minimize or prevent 
the AgNPs side effects. In this work, AgNPs were stabilized onto polyamide 6.6 fabrics (PA66) 
through Dielectric barrier discharge (DBD) plasma treatment and the use of chitosan (Ch) layers. On 
the one hand, DBD plasma treatment, a low‐cost and dry environmental‐friendly system, can be 
applied to activate the surface of the fabrics promoting physical and chemical modifications. It 
introduces new polar functional groups and increases the surface roughness that has demonstrated 
to improve the AgNPs adhesion [8]. On the other hand, Ch is a biopolymer with large‐scale 
availability, different bioactivities, biodegradable and biocompatible. It is very useful in biomedical 
applications, able to prevent microbial growth and promote wound healing [9,10] The main objective 
of this work is to obtain improved AgNPs deposition and controlled ions released. It will allow the 
development of novel and safe wound dressings. The combination of DBD plasma treatment and 
different layers of Ch makes it possible to control the amount and oxidation state of nanoparticles in 
the composites. Thus, it will be possible to manage the antimicrobial performance of the composites 
and minimize the AgNPs side effects. 
2. Experiments 
2.1. Materials 
PA66 knitted fabric with weight per unit area of 240 g m−2 was selected for this study. The fabric 
was pre‐washed with a non‐ionic detergent (1 g L−1) at 60 C for 60 min., rinsed with distilled water 
and dried at 40 C. Polyvinylpyrrolidone‐coated AgNPs (~20 nm) were analytical grade purchased 
from Sigma‐Aldrich, St. Louis, MO, USA and used without further purification. Chitosan at 1600 Cps 
(~350 MW) was obtained from Primex, Iceland. 
2.2. DBD Plasma Treatment 
The DBD plasma treatment was performed in a semi‐industrial prototype machine (Softal 
GmbH/University of Minho) working at room temperature and atmospheric pressure in air, using a 
system of metal electrode coated with ceramic and counter electrodes coated with silicon with 50 cm 
effective width, gap distance fixed at 3 mm and producing the discharge at high voltage 10 kV and 
low frequency 40 kHz. The machine was operated at previous optimized parameters (1 kW of power 
and velocity of 4 m min−1) [11]. The applied dosage was 5.0 kW min m−2. 
2.3. Composites Preparation 
AgNPs was dispersed in ethanol (1 mg mL−1) by a Branson 3510 ultrasonic bath (30 min) and an 
Optic Ivymen System CY 500 ultrasonic tip (15 min). Ch solution (0.25% (w/v)) was prepared by 
dissolving in acetic acid (1% (v/v)) water solution. Different composite formulations with and 
without DBD plasma treatment were obtained by spray in both sides of the PA66 samples (10 × 10 
cm), with the system pressurized at 1.5 bar and maintained at the distance of 5 cm to the substrate. A 
Proceedings 2020, 4, x FOR PEER REVIEW 3 of 8 
 
first layer of Ch was applied, followed by a second layer of AgNPs (Ch + AgNPs). A final protective 
layer was also considered (Ch + AgNPs + Ch) and samples with just AgNPs were used as control. 
2.4. Scanning Electron Microscopy (SEM) 
Morphological analyses of PA66 knitted fabrics were carried out with an Ultrahigh resolution 
Field Emission Gun Scanning Electron Microscopy (FEG‐SEM), NOVA 200 Nano SEM, FEI Company 
(Hillsboro, OR, USA). Secondary electron images were achieved with an acceleration voltage at 5 kV. 
Backscattering Electron Images were performed with an acceleration voltage of 15 kV. Samples were 
covered with a film of Au–Pd (80–20 weight %) in a high‐resolution sputter coater, 208 HR 
Cressington Company (Oxhey, Watford, UK), coupled to a MTM‐20 Cressington High Resolution 
Thickness Controller. 
2.5. X-Ray Photoelectron Spectroscopy (XPS) 
XPS analyses were performed using a Kratos AXIS Ultra HAS (Kratos Analytical Limited, 
Manchester, UK), with VISION software (Vision 2, Kratos Analytical Limited, Manchester, UK) for 
data acquisition and CASAXPS software (casaXPS 2.3.22. Casa Software Ltd., Teignmouth, UK) for 
data analysis. The analysis was performed with a monochromatic Al Kα X‐ray source (1486.7 eV), 
operating at 15 kV (150 W), in FAT (Fixed Analyser Transmission) mode, with a pass energy of 40 eV 
for regions ROI and 80 eV for survey. Data acquisition was performed with a pressure lower than 10‐
6 Pa, and it was used as a charge neutralization system. Spectra have been charge corrected to give 
the adventitious C1s spectral component (C‐C. C‐H) a binding energy of 285 eV. High‐resolution 
spectra were collected using an analysis area of ≈1 mm2. The peaks were constrained to have equal 
FWHM (Full Width at Half Maximum) to the main peak. This process has an associated error of ±0.1 
eV. Spectra were analysed for elemental composition using CASAXPS software (version 2.3.15). 
Deconvolution into sub‐peaks was performed by least‐squares peak analysis software. XPSPEAK 
version 4.1 (Prof. Raymond W.M. Kwok, Chinese University of Hong Kong, Hong Kong, China). 
using the Gaussian/Lorenzian sum function and Shirley‐type background subtraction. No tailing 
function was considered in the peak fitting procedure. The components of the various spectra were 
mainly modelled as symmetrical Gaussian peaks unless a certain degree of Lorentzian shape was 
necessary for the best fit. The best mixture of Gaussian‐Lorentzian components was defined based 
on the instrument and resolution (pass energy) settings used as well as the natural line width of the 
specific core hole. 
2.6. Antimicrobial Analyses 
The antibacterial efficacy of the PA66 composites was measured quantitatively according to the 
standard shake flask method (ASTM‐E2149‐01). Gram‐positive and Gram‐negative bacteria were 
used. Staphylococcus aureus (S. aureus, ATCC 6538) and Escherichia coli (E. coli, ATCC 25922), 
respectively. The experiment was conducted aseptically to ensure the absence of any contamination. 
Bacteria inoculum were prepared from a single colony and incubated overnight in tryptic soy broth 
(TSB, Merck) at 37 °C and 120 rpm. Each test was carried out using an initial concentration of 1.5–3.0 
× 107 CFUs/mL in PBS. PA66 samples of 0.05 g weight were incubated in 5 mL of bacteria suspension 
at 37 °C and 100 rpm. Before contact with samples (0 h) and after contact with samples (24 h), the 
bacteria were serially diluted, cultured onto tryptic soy agar (TSA, Merck) plates, and further 
incubated for 24 h. The results were obtained by counting the colonies of surviving bacteria on the 
agar plates. Antimicrobial activity was reported in terms of log reduction, calculated as the ratio 
between the number of surviving bacteria colonies present on the TSA plates. before and after contact 
with the samples. All antimicrobial experiments were conducted in triplicate. 
3. Results 
Novel composites were produced using chitosan (Ch) to stabilize AgNPs onto untreated and 
DBD plasma treated polyamide. The different formulations were obtained by spray where a first 
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layer of Ch was applied, followed by a second layer of nanoparticles dispersed in ethanol (Ch + NPs). 
A final protective layer was also considered (Ch + NPs + Ch) and samples with just NPs were used 
as control. 
3.1. SEM 
SEM analyses of PA66 untreated and DBD plasma‐treated composites were employed to 
evaluate the distribution and the aglomeration of AgNPs deposited into the samples, and also to 
confirm the allocation of the final Ch protection layer (Figure 1). The low magnification was applied 
to analyze the AgNPs distribution (1000×) and a higher magnification was used to assess the 
nanoparticles aglomeration and the Ch layers (5000×). 
 
 
Figure 1. SEM images of untreated (a,c,d) and DBD plasma treated (b,e) of control samples (a,b) and 
Ch + AgNPs + Ch composites (c–e) with magnification of 1000× (a–c,e) and 5000× (d). 
3.2. XPS 
XPS analysis was carried out to compare the surface atomic percentage of oxygen, carbon, 
nitrogen and silver in the composites, and calculate the respective atomic ratios (O/C and N/C) (Table 
1). The chemical modifications of composites by DBD plasma treatment and Ch layers were evaluated 
by the chemical bonding information. This data was obtained by the deconvolution spectra of C1s, 
N1s, O1s, and Ag3d (Tables 2 and 3). 
Table 1. Relative chemical composition of untreated (UT) and DBD plasma‐treated (DBD) PA66 
samples. 
Samples C (At%) O (At%) N (At%) Ag (At%) O/C Ratio N/C Ratio 
AgNPs UT 61.7 21.5 11.9 4.8 0.3 0.2 
AgNPs DBD 58.4 24.1 11.2 6.3 0.4 0.2 
Ch + AgNPs UT 61.6 25.2 11.5 1.7 0.4 0.2 
Ch + AgNPs DBD 55.4 32.0 8.5 4.1 0.6 0.2 
Ch + AgNPs + Ch UT 62.0 23.5 11.0 3.4 0.4 0.2 
Ch + AgNPs + Ch DBD 53.6 31.9 11.2 3.4 0.6 0.2 
  
a b 
c d e 
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Table 2. Deconvolution analysis of the C1s and O1s peaks for the untreated (UT) and DBD plasma‐
treated (DBD) PA66 samples (SD ± 0.3 eV), results are presented as a percentage of relative area. 


















AgNPs UT ‐ 70.8 15.8 13.4 ‐ 71.4 22.7 5.9 
AgNPs DBD ‐ 67.9 16.8 13.4 1.9 61.2 28.8 10.0 
Ch + AgNPs UT ‐ 66.8 19.0 14.1 ‐ 64.0 28.6 7.4 
Ch + AgNPs 
DBD 
1.3 52.2 25.5 17.0 4.1 43.1 43.3 13.6 
Ch + AgNPs + 
Ch UT 
‐ 70.2 17.5 12.3 ‐ 62.8 30.4 6.7 
Ch + AgNPs + 
Ch DBD 
1.5 55.1 24.0 16.9 2.4 50.2 42.2 7.6 
Table 3. Deconvolution analysis of the N1s and Ag3d peaks for the untreated (UT) and DBD plasma‐
treated (DBD) PA66 samples (SD ± 0.3 eV), results are presented as a percentage of relative area. 
















AgNPs UT 89.8 ‐ 10.2 53.1 14.3 32.6 ‐ 
AgNPs DBD 87.1 ‐ 12.9 43.5 15.3 27.8 13.4 
Ch + AgNPs UT 79.8 13.1 7.1 46.3 ‐ 53.7 ‐ 
Ch + AgNPs DBD 56.1 31.0 12.9 45.7 12.9 23.9 17.5 
Ch + AgNPs + Ch 
UT 
81.8 10.9 7.2 35.9 17.8 32.4 13.9 
Ch + AgNPs + Ch 
DBD 
47.7 40.6 11.7 41.7 13.8 35.3 9.2 
3.3. Antimicrobial Analyses 
The quantitative antibacterial activity was evaluated against S. aureus and E. coli after 2 and 24 
h by shake flask method (Figure 2). 
  
Figure 2. Antimicrobial action of untreated and DBD‐plasma treated samples with AgNPs and 
different layers of Ch against S. aureus (A) and E. coli (B) after 2 h (dotted fill) and 24 h (solid fill). 
4. Discussion 
4.1. SEM 
SEM images confirmed the presence of AgNPs uniformly distributed in both DBD plasma‐
treated and untreated analyzed samples but it was not possible to validate if DBD plasma treatment 
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enhanced the AgNPs deposition rates on the fabric’s surface (Figure 1). Thus, the chemical 
composition was calculated in XPS analysis and will be discussed in the respective section. The 
collected images also showed some nanoparticles agglomeration in all samples, independently if the 
AgNPs are deposited directly in the fabric samples or after the first layer of chitosan. These results 
suggest that with the AgNPs deposition by spray, the agglomeration was independent of the DBD 
plasma treatment and chitosan layer, it is only related to the initial AgNPs dispersion in ethanol. 
Previous DLS studies showed that 20 nm polyvinylpyrrolidone‐coated AgNPs ethanol dispersions, 
at the same concentration, present some agglomeration with an average size of 281.0 ± 1.5 nm [12]. 
The final chitosan layer is clearly visible mainly when the higher magnification is applied (Figure 1d). 
The exposure of AgNPs decreased but the coating is not completely uniform. Upcoming studies may 
be planned to reduce the nanoparticles agglomeration and improve the chitosan final layer. 
4.2. XPS 
The relative chemical composition of C, N, O and Ag in PA66 composites and control samples 
were calculated using XPS results (Table 1). DBD plasma treatment revealed a crucial role in 
nanoparticles adhesion, 4.8 and 6.3 At% in control samples. The first layer of Ch decreased the 
nanoparticles adhesion in both untreated and DBD plasma‐treated samples but treated samples 
showed higher concentration (1.7 and 4.1 At%). DBD plasma‐treated samples displayed an increase 
in oxygen content and O/C ratio (Table 1). This difference was even more evident in samples with Ch 
layers. Thus, the results confirmed the integration of oxygen species from the air during the plasma 
treatment (21.5 and 24.1 At% for control samples). In addition to the superior AgNPs adhesion in 
DBD plasma treated samples, also superior adsorption of chitosan in DBD plasma‐treated was 
observed (for Ch+AgNPs samples, 25.2 and 32.0 At%). DBD plasma treatment is able to change the 
surface properties of PA66 fabrics, providing more roughness surfaces and newly reactive oxygen 
species [13]. The deconvolution spectra of C1s, N1s, O1s, and Ag3d highlighted the chemical 
modifications of PA66 surface due to DBD plasma treatment and chitosan layers (Tables 2 and 3). 
The C1s envelopes of untreated samples presented the usual three peaks at 285.0, 286.3 and 287.9 eV 
attributed to C‐C/C‐H, C‐N and O=C‐N bonds, respectively [14]. DBD plasma‐treated samples 
showed the same peaks and another new peak at 289.3 eV attributed to O‐C=O bonds, evidencing the 
introduction of novel oxygen species by DBD plasma treatment [15]. PA66 composites with both DBD 
plasma treatment and Ch layers showed an additional minor peak at 283.2 eV attributed to C‐C/C=C 
bonds due to the interactios between silver ions and chitosan hydrocarbons [12,16,17]. The O1s 
spectra showed three peaks attributed to O=C (531.4 eV), HO–C bonds (533.0 eV) and O‐C=O (533.9 
eV). The peak at 531.4 eV was prevalent in all composites. However, after DBD plasma‐treatment, 
this peak decreased and the other oxygen peaks increased, suggesting a strong PA66 surface 
oxidation. The N1s region deconvolution, in control samples presented two peaks at 399.8 and 401.4 
eV, attributed to N‐C and N‐H, respectively [18–20]. The composites with chitosan presented an extra 
peak at 400.4 eV corresponding to amine groups of chitosan [21]. These deconvolutions proved the 
superior adhesion of chitosan in DBD plasma‐treated samples. The Ag3d deconvolution spectra 
showed the oxidation states of AgNPs in the different formulations. Two doublets appeared, one 
attributed to metal silver at 368.3 (Ag 3d5/2) and 374.6 eV (Ag 3d3/2) and other attributed to ionic 
silver in AgNPs surface at 370.0 and 376.0 eV [22,23]. The intensity of the second doublet was superior 
in DBD plasma‐treated control and Ch + AgNPs samples, indicating a superior AgNPs oxidation in 
these samples. Interestingly, when a final layer of chitosan is applied (Ch + AgNPs samples), DBD 
plasma treatment did not influence the oxidation state of AgNPs and the second doublet did not 
increase, suggesting that chitosan operated as a coating to protect the AgNPs from oxidation. 
4.3. Antimicrobial Analyses 
The antibacterial activity was evaluated against S. aureus and E. coli after 2 and 24 h (Figure 2). 
The results showed to be according to AgNPs oxidation state and chitosan concentration. For S. 
aureus, DBD plasma treatment and the Ch in the first layer of the composite delayed the antimicrobial 
action that can be related to the superior adhesion of chitosan in these samples. After 24 h, treated 
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samples showed better or equivalent results, showing suitable properties to control the antimicrobial 
action during this period. For E. coli, all DBD plasma‐treated samples showed a superior action. Just 
the first layer of chitosan was able to delay the antimicrobial action. When the final layer of chitosan 
was applied, the antimicrobial action increases even after 2 h. In some cases, the final Ch layer 
enhances the antimicrobial action of the composites. 
5. Conclusions 
This study showed the potential of DBD plasma treatment to improve or control the 
antimicrobial action of composites treated with this technology. Depending on the composite 
formulation, it was possible to perform a rapid antimicrobial action or control it. It demonstrated to 
be a suitable method to improve the adhesion of both AgNPs and chitosan. Some future experiments 
must be performed to improve the uniformity of chitosan deposited layers, decrease the AgNPs 
agglomeration and decrease the AgNPs concentration. The obtained coatings can be used for the 
development of novel and safe wound dressings with improved properties. 
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